scholarly journals Professional Support in Pregnancy Influence Maternal Relation to and Feelings for the Baby after Cesarean Birth: An Intervention Study

2012 ◽  
Vol 01 (04) ◽  
Author(s):  
Stina Thorstensson
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Maria Bich-Thuy Truong ◽  
Elin Ngo ◽  
Hilde Ariansen ◽  
Ross T. Tsuyuki ◽  
Hedvig Nordeng

Abstract Background Maternal wellbeing and quality of life (QOL) are increasingly being recognized as important for healthy pregnancies. The aim of this study was to investigate the impact of a pharmacist consultation on pregnant women’s QOL focusing on nausea and vomiting in pregnancy (NVP), and patient satisfaction. Methods For this intervention study in 14 community pharmacies, women in early pregnancy were recruited and assigned to a pharmacist consultation (intervention) or standard care (control). The consultation aimed to address each woman’s concerns regarding medications and pregnancy-related ailments. Data were collected through online questionnaires at baseline (Q1) and during the second trimester (Q2). The intervention group completed an additional satisfaction questionnaire after the consultation was completed. The primary outcome was the impact of the intervention on the Quality of Life Scale (QOLS) scores between the first and second trimesters. The impact of the intervention was assessed by linear regression, and secondary analyses were performed to assess effect modification by NVP. Results Of the 340 women enrolled in the study, we analyzed data for 245. Half (170/340) of the original participants were allocated to the intervention group, of whom 131 received the pharmacist consultation. Most women (75%, 78/96) reported that the consultation was useful to a large/very large extent. The consultation had no overall impact on QOLS scores between the first and the second trimesters compared with standard care (adjusted β: 0.7, 95% CI: -2.1, 3.4). The impact of the intervention on QOLS was greater amongst women with moderate/severe NVP (adjusted β: 3.6, 95% CI: -0.6, 7.7) compared to those with no/mild NVP (adjusted β: -1.4, 95% CI: -5.1, 2.2) (interaction term study group*NVP severity, p = 0.048). Conclusions The pregnant women highly appreciated the pharmacist consultation, but the intervention did not affect their QOL scores compared with standard care. Future studies should further explore the effect of a pharmacist consultation specifically for NVP and on other outcomes such as use of health care services and medication use in pregnancy. Trial registration Retrospectively registered in ClinicalTrials.gov (identifier: NCT04182750, registration date: December 2, 2019).


Addiction ◽  
2015 ◽  
Vol 110 (4) ◽  
pp. 680-688 ◽  
Author(s):  
Diana Ierfino ◽  
Eleni Mantzari ◽  
Julie Hirst ◽  
Tina Jones ◽  
Paul Aveyard ◽  
...  

2017 ◽  
Vol 216 (1) ◽  
pp. S506-S507
Author(s):  
Emmely van der Steen ◽  
Julia Spaan ◽  
Laura D. de Wit ◽  
Jeroen Brogtrop ◽  
Pieter J. van Runnard Heimel

2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Theresa M Marteau ◽  
Josephine Thorne ◽  
Paul Aveyard ◽  
Julie Hirst ◽  
Rachel Sokal

2021 ◽  
pp. 104973232110413
Author(s):  
Jane Lockton ◽  
Melissa Oxlad ◽  
Clemence Due

Pregnancy loss and neonatal death are recognized as distressing experiences for parents and other family members. However, no research has specifically addressed the experiences of grandfathers. This study aimed to understand grandfathers’ grief experiences, and to identify supports they provide, receive, and desire following the loss of a grandchild in pregnancy or the neonatal period. Semi-structured interviews with 10 Australian grandfathers were analyzed, applying principles of thematic analysis. Three themes related to grief and three themes related to support were identified. Findings indicated that grandfathers expressed grief in a range of ways, and emotional expressiveness did not reflect the extent of their grief. Grandfathers typically provided extensive support to their child and family; however, few supports were available to help grandfathers. Recognition and validation of grandfathers’ grief, early access to information, and guidance to a variety of supports including written materials, peer and professional support, is required.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Aneesa Thannickal ◽  
Brandon Maddy ◽  
Marla DeWitt ◽  
William Cliby ◽  
Margaret Dow

Abstract Background Ovarian dysgerminoma, a subtype of malignant germ cell tumor (GCT), is a rare ovarian neoplasm that is infrequently found in the gravid patient. When dysgerminomas do occur in pregnancy, the rapidly growing tumors can have a heterogeneous presentation and lead to peripartum complications and morbidity. Due to the rarity of this condition, diagnostic and therapeutic strategies are not well described in the literature. Case presentation A healthy multigravida with an uncomplicated antenatal history presented for elective induction of labor. She had a protracted labor course, persistently abnormal cervical examinations, and eventually developed a worsening Category II tracing that prompted cesarean birth. Intraoperatively, a 26 cm pelvic mass later identified as a Stage IA dysgerminoma was discovered along with a massive hemoperitoneum. The mass was successfully resected, and the patient remains without recurrence 6 months postoperatively. Conclusion Although rare and generally indolent, dysgerminomas can grow rapidly and cause mechanical obstruction of labor and other complications in pregnancy. Pelvic masses, including malignant neoplasms, should be included in as part of a broad differential diagnosis when evaluating even routine intrapartum complications such as abnormal labor progression. Additionally, we demonstrate that adnexal masses can be a source of life-threatening intraabdominal hemorrhage.


2005 ◽  
Vol 13 (3-4) ◽  
pp. 145-147
Author(s):  
Ljiljana Mladenovic-Segedi ◽  
Petar Novakovic ◽  
Aljosa Mandic ◽  
Olgica Mihajlovic ◽  
Tatjana Ivkovic-Kapicl

Cervical cancer is the most frequently diagnosed malignant disease in pregnancy. The clinical symptoms are scarce or none. The diagnosis is made primarily with a cervical smear, as well as a colposcopic examination and directed cervical biopsy. The treatment of cervical cancer depends on the stage of the disease, the gestation period, and a patient?s wish to carry a pregnancy to term. The illustrated case is of a patient who with the diagnosed presence of microinvasive squamous cell cancer, due to cervical biopsy, in the 1st trimester of pregnancy. In the 2nd trimester, diagnostic conization was performed in order to exclude the presence of the invasive disease. The definite histopathologic findings indicated the presence of cancer in situ. The conization margins were negative and thus the patient was successfully cured. The patient had a cesarean birth in the 36th week of pregnancy and she gave birth to an alive female newborn. Women are given the chance to have cervical cancer diagnosed and treated in the early stages of pregnancy owing to the introduction of a cervical smear in the modern protocol of antenatal protection.


Sign in / Sign up

Export Citation Format

Share Document